688687.SH
Beijing Kawin Technology Share-Holding Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 16.30
+1.81%Year over year
Reported trailing growth
- Revenue
- +3.8%
- EBITDA
- —
- EBIT
- -78.6%
- EPS
- -91.4%
- Free cash flow
- +69.0%
- Operating cash flow
- -22.4%
Forward estimates
Based on analyst estimates
- Revenue
- -53.9%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- -5.6%
- EBIT
- -14.2%
- Net income
- -28.4%
- EPS
- -28.4%
- Free cash flow
- +85.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026